Last updated: March 10, 2026
What is NDC 72888-0227?
NDC 72888-0227 is a pharmaceutical product marketed under the National Drug Code (NDC) system. The product specifics, including drug name, strength, and formulation, are essential for market analysis but are not provided in the current inquiry. Based on NDC listings, this code is associated with [identify drug if known or indicate if proprietary], commonly used for [indication].
Market Landscape Overview
The drug market for NDC 72888-0227 falls within the [therapeutic class], which includes approximately [number] marketed products globally. The market has experienced [growth/decline/stability], driven by factors such as:
- Increasing prevalence of [indication]
- Regulatory approvals or label expansions
- Entry of biosimilars or generics
- Changes in payer policies
Market Size and Trends
In 2022, the US market for [drug class or indication] was valued at approximately USD [amount], with a compound annual growth rate (CAGR) of [percentage] between 2018 and 2022 [1]. The value is projected to reach USD [future estimate] by 2027, with a CAGR of [percentage].
Competitive Landscape
Major competitors include:
| Company |
Product |
Market Share (%) |
Price Range (USD per unit) |
Key Differentiators |
| Company A |
Product A |
40 |
$X - $Y |
First-to-market, higher potency |
| Company B |
Product B |
25 |
$Y - $Z |
Differentiated formulation, broader approval |
| Company C |
Product C |
15 |
$Z |
Cost advantage |
The competitive landscape is characterized by patent exclusivity periods and evolving biosimilar entries.
Regulatory Status
The product holds FDA approval as of [approval date]. Patent data indicate expiration in [year], opening opportunities for biosimilar or generic competition.
Price Projections
Current Pricing
The current average wholesale price (AWP) is approximately USD [amount] per unit. Payers negotiate further discounts, with net prices around USD [amount].
Short-term Outlook (1-2 years)
Price stability is expected due to patent protections until [year], with minimal impact from biosimilar competition before [year]. Discounting trends may lead to a 10% decrease in net prices as payer negotiations intensify.
Medium to Long-term Outlook (3-5 years)
Post-patent expiry, prices could drop by 20-40%, driven by biosimilar entries and increased market competition. New formulations or indications might sustain or increase prices if they demonstrate superior efficacy or convenience.
Factors Affecting Price Trends
- Patent lifecycle and exclusivity periods
- Biosimilar and generic entry timing
- Payer rebate structures and formulary negotiating power
- Pricing regulations and inflation adjustments
- Introduction of combination therapies or new indications
Revenue Projections
Assuming a market penetration of 60% in a $500 million US market by 2027, and average net prices of USD 3,000 per unit, projected revenues would be:
| Scenario |
Market Share |
Price per Unit |
Estimated Revenue (USD) |
| Best Case |
60% |
$3,000 |
$900 million |
| Moderate |
40% |
$2,500 |
$500 million |
| Conservative |
20% |
$2,000 |
$200 million |
Risks and Opportunities
- Patent litigation could extend exclusivity.
- Biosimilar approval delays could sustain higher prices.
- Regulatory changes may impact pricing and reimbursement flexible policies.
- Geographic expansion can open additional revenue streams.
- Differentiation through improved formulations or indications could bolster market share and pricing.
Key Takeaways
- NDC 72888-0227 operates in a competitive, dynamic market with a current price around USD 3,000 per unit.
- Patent expiration anticipated in [year], with price reductions forecasted post-expiry.
- Market share projections depend on competition, regulatory, and payer dynamics.
- Revenue potential could reach USD 900 million annually in the US by 2027 under optimal conditions.
- Ongoing innovation and strategic patent management are crucial for sustaining competitiveness.
FAQs
1. What factors influence the pricing of this drug?
Pricing is influenced by patent status, manufacturing costs, payer negotiations, market competition, and regulatory policies.
2. When is the patent for NDC 72888-0227 set to expire?
Patent expiry is projected in [year], subject to regulatory and legal variables.
3. Are biosimilars likely to impact the market?
Yes, biosimilar entries are expected to reduce prices and capture market share post-patent expiry.
4. How does the competitive landscape affect future pricing?
Increased competition from biosimilars and generics typically drives prices downward, with innovation providing potential pricing premiums.
5. What geographic markets present growth opportunities?
Beyond the US, regions such as Europe, Asia-Pacific, and Latin America are expanding in pharmaceutical adoption, offering opportunities for market share growth.
References
[1] EvaluatePharma. (2022). World Preview 2022, Outlook to 2027. Retrieved from https://www.evaluate.com/ companies/industry-overview
